Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Birth of a standard: MET-RADS-P for metastatic prostate cancer

Nature Reviews Urology volume 13, pages 568–570 (2016)Cite this article

Subjects

METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) is the first effort to provide the burgeoning field of whole body-MRI (WB-MRI) with minimum standards of image acquisition, interpretation, and reporting; it should act as a catalyst for promoting the use of this promising method.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Lecouvet, F. E. et al. Monitoring the response of bone metastases to treatment with magnetic resonance imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group. Eur. J. Cancer 50, 2519–2531 (2014).

    Article  CAS  PubMed  Google Scholar 

  2. Padhani, A. R. et al. METastasis Reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2016.05.033 (2016).

  3. Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228–247 (2009).

    Article  CAS  PubMed  Google Scholar 

  4. Weinreb, J. C. et al. PI-RADS Prostate Imaging — Reporting and Data System: 2015, Version 2. Eur. Urol. 69, 16–40 (2016).

    Article  PubMed  Google Scholar 

  5. Turkbey, B. & Choyke, P. L. PIRADS 2.0: what is new? Diagn. Interv. Radiol. 21, 382–384 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Koh, D. M. et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am. J. Roentgenol. 199, 252–262 (2012).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Baris Turkbey and Peter L. Choyke are at the Molecular Imaging Program, National Cancer Institute, US National Institutes of Health, 10 Center Drive, Room B3B69, Bethesda, Maryland 20892, USA.,

    Baris Turkbey & Peter L. Choyke

Authors
  1. Baris Turkbey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter L. Choyke
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

B.T. researched data for article, and wrote the manuscript. Both authors made substantial contributions to discussion of content and reviewed and edited manuscript before submission.

Corresponding author

Correspondence to Baris Turkbey.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Turkbey, B., Choyke, P. Birth of a standard: MET-RADS-P for metastatic prostate cancer. Nat Rev Urol 13, 568–570 (2016). https://doi.org/10.1038/nrurol.2016.163

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.163

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research